The KQ Labs portfolio
KQ Labs launched with its first cohort in 2018. Find out more about the companies who have taken part in the accelerator.
CSS amends
Cohort 5: 2022-23
CARDIATEC
CardiaTec is a University of Cambridge spin-out, pioneering in cardiovascular drug discovery with its AI-driven multi-omics drug target discovery platform.
careloop health
Digital therapeutics to predict and prevent relapse in severe mental illness.
cytecom
Cytecom is on a mission to fight antimicrobial resistance (AMR) by electrocuting bacteria to detect live cells and provide AMR profiles at point-of-care, informing the correct targeted antimicrobial therapy sooner than any other test.
damahealth
Dama Health is on a mission to personalise contraception and other areas of female health by leveraging technology and genomics.
proxximos
Proxximos offers next generation digital contact traicing, delivering a step change in infection control for any setting.
rarecan
RareCan is the only health tech company in the UK that specialises in supporting patients with rare cancers.
storegene
One test: infinite insights. StoreGene's clinical genomic operating system enables rapid translation of genetic research to genome insights for data-driven precision medicine.
strolll
Strolll develops digital therapeutics (DTx) software for augmented reality glasses that empowers movement therapy for people living with neurological disorders.
Cohort 4: 2021-22
Concinnity Genetics
Concinnity Genetics is improving the safety and efficacy of gene therapies using AI.
Diabetech
Diabetech is the next generation digital product for behaviour change in chronic health conditions such as diabetes.
They offer behavioural rewards and behavioural coaching to increase adherence rates and help diabetics better manage their condition.
Eczemadoc
Eczemadoc is a full-stack solution using patient reported data, machine learning and personalised coaching to predict and prevent eczema flare ups.
Enedra Therapeutics
Enedra is checkmating cancer’s best moves by creating a new generation of drugs that target tumour evolution and heterogeneity using synthetic lethality and AI.
Exogene
Exogene enables the discovery of T-cell receptor (TCR)-based cell therapies to cure advanced solid cancers, by combining AI and high throughput TCR screening in the lab.
Latchaid
LatchAid is an award-winning femtech start-up using cutting-edge 3D interactive technology and artificial intelligence to support women through the breastfeeding and motherhood journey 24/7.
Lindus health
Lindus Health's mission is to accelerate research for the next generation of healthcare companies.
They are building the world’s first full stack clinical trial platform to conduct faster, safer clinical trials, improving health outcomes for everyone.
Multiplai
MultiplAI is developing universal genomic screening for cardiovascular diseases using RNA sequencing and machine learning.
Bringing liquid biopsy to cardiovascular disease diagnosis enables a breakthrough in access to preventative care and precise prognosis for anyone on the planet.
neurovirt
NeuroVirt is a medtech company that uses virtual reality (VR) and in-house hardware to gamify rehabilitation for post-stroke patients and quantify measurements of hand impairment and improvement for doctors.
Queen Square Analytics
Queen Square Analytics is bringing advanced image analysis technology to the treatment of neurological diseases (starting with Multiple Sclerosis).
Cohort 3: 2020-21
AI VIVO
AI VIVO uniquely combines systems biology and machine learning/AI to build a disruptive platform technology to accelerate drug discovery.
Benetalk
Benetalk has developed a digital speech therapist that monitors speaking patterns and provides immediate feedback to help people who stutter to master fluency speaking habits during daily activities.
brightlobe
Brightlobe develops cutting-edge technology that can intelligently assess and support a child’s developmental trajectory through mobile games and smart toys.
CharcoNeurotech
Charco Neurotech have developed CUE1, a non-invasive wearable device for Parkinson’s, utilising pulsed cueing and focused vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement.
GlamorousAI
GLAMOROUS AI has a novel approach to chemical design and optimisation. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable applications where only limited data points are available.
Itecho Health
Itecho Health provides digital health applications and services for the monitoring and management of long-term or chronic conditions.
Little Journey
Little Journey use technology, research and data to transform healthcare and research outcomes through an end to end psychological preparation and support tool for children and their families.
mpixl
Mpixl combines deep learning and MRI radiology for faster and kinder care of leukaemia patients.
Oxford Cancer Analytics
Oxford Cancer Analytics aims to revolutionise early cancer detection and treatment through affordable blood tests using automated machine learning platforms for data analysis, biomarker discovery and patient stratification.
Syrona Health
Syrona is a personalised digital women's health screening and digital therapeutics platform, with a first focus on endometriosis.
Cohort 2: 2019-20
Baseimmune
Baseimmune is a company created to offer data-driven solutions to vaccine design. Our mission is to monitor and integrate big-data on genomics, proteomics, as well as geographical and clinical data into antigen discovery and vaccine development.
Bold Health
Bold Health is a digital therapeutic platform leveraging behavioural medicine and data science to create personalised care programs for the self-management of chronic digestive conditions.
Imera
Imera uses machine learning to support radiologists to identify fractures in patients more effectively.
Jiva.ai
Jiva.ai is a machine learning platform that puts model integration at the centre of its data science workflow and is currently engaged in identification and diagnosis of prostate cancer from MRI scans.
My personal therapeutics
My Personal Therapeutics identifies highly precise combinations of FDA-approved drugs to target an individual patient’s tumour.
Oppilotech
Oppilotech developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the platform to identify first-in-class drug targets and develop drugs that modulate them.
Pexxi
Pexxi is a precision medicine platform, matching women with the optimal oral contraceptives based on their medical history, hormone levels and genetic profile.
Pharmenable
PharmEnable explores new areas of the chemical space that no one else is currently searching to enable the development of vital new medicines.
Sano Genetics
Sano Genetics is a platform for personalised medicine that connects people with relevant research studies and clinical trials based on their genetic and health data.
Zetta Genomics
Zetta Genomics provides the big data foundation for generation genome. Our distributed storage and analysis technology provides the quality and convenience needed to move genomics from research to medicine at scale.
Cohort 1: 2018-19
Concr
ConcR focuses on cancer resistance and data driven predictions of patient outcome based on multi-omics data.
cortirio
Head injuries are the leading cause of death and disability among the under 45s. Cortirio are developing portable brain imaging to diagnose head injuries at the point of care.
Deepscope
Deepscope is the first free ultrasound simulator for mobile devices. It enables healthcare professionals both to learn, using the free mobile app, and to teach, by easily creating their own clinical simulations.
Heron
Heron have created a graphical and navigable map of science, helping researchers, clinicians and industry gain more value from scientific literature.
Macusoft
Macular disease is the biggest cause of preventable sight loss in the developed world. Macusoft is developing clinical data and genomics based AI systems to support treatment to prevent avoidable blindness.
Mendelian
Mendelian accelerates the diagnosis of rare genetic diseases by building smart software solutions for clinicians, health providers and patients.
Okko
Okko are working on re-designing the eye chart. They are developing eye disease diagnosis and tracking through home monitoring.
quin
Quin uses science, engineering and design to help people who take insulin make the best possible decisions.
Vesynta
Vesynta personalizes dosing of life-saving therapies through a desktop blood monitoring lab for rapid drug quantification, advancing medicines optimization and patient health outcomes.
ELU AI
ELU AI is unlocking the secrets of blood, addressing the problem of deteriorating patients with initial focus on Acute Kidney Injury
